- Question from Elizabeth: Are there any studies comparing the 3 different aromatase inhibitors? Is any one better than another?
- Answers - Patricia A. Ganz, M.D. At this time, we do not have any what we would call head-to-head comparisons of the 3 drugs. I believe there is a trial underway now that may be looking at this. There is some speculation that exemestane, which is Aromasin, may be safer for the bones because it is a steroidal aromatase inhibitor. But there have been no studies to demonstrate that.
The Ask-the-Expert Online Conference called Managing Ongoing Medications featured Patricia Ganz, M.D. and moderator Lillie Shockney, R.N., B.S., M.A.S. answering your questions about staying on track with breast cancer medications you have to take on a regular basis.
Editor's Note: This conference took place in August 2007.
The materials presented in these conferences do not necessarily reflect the views of Breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.
A production of LiveWorld, Inc.
Copyright 2010. All rights reserved.